Brainsway Ltd (BWAY) - Total Liabilities
Based on the latest financial reports, Brainsway Ltd (BWAY) has total liabilities worth $34.67 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Brainsway Ltd cash flow conversion to assess how effectively this company generates cash.
Brainsway Ltd - Total Liabilities Trend (2000–2025)
This chart illustrates how Brainsway Ltd's total liabilities have evolved over time, based on quarterly financial data. Check BWAY financial resilience to evaluate the company's liquid asset resilience ratio.
Brainsway Ltd Competitors by Total Liabilities
The table below lists competitors of Brainsway Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ethan Allen Interiors Inc
NYSE:ETD
|
USA | $236.68 Million |
|
Kaveri Seed Company Limited
NSE:KSCL
|
India | Rs8.42 Billion |
|
V-Mart Retail Limited
NSE:VMART
|
India | Rs17.81 Billion |
|
mF International Limited Ordinary Shares
NASDAQ:MFI
|
USA | $21.51 Million |
|
Sequent Scientific Limited
NSE:SEQUENT
|
India | Rs8.40 Billion |
|
Zhejiang Dibay Electric Co Ltd
SHG:603320
|
China | CN¥219.86 Million |
|
Suli Co Ltd
SHG:603585
|
China | CN¥2.24 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down Brainsway Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BWAY market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Brainsway Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Brainsway Ltd (2000–2025)
The table below shows the annual total liabilities of Brainsway Ltd from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $34.67 Million | +8.32% |
| 2024-12-31 | $32.00 Million | +49.61% |
| 2023-12-31 | $21.39 Million | +12.11% |
| 2022-12-31 | $19.08 Million | +3.66% |
| 2021-12-31 | $18.41 Million | +28.03% |
| 2020-12-31 | $14.38 Million | -0.96% |
| 2019-12-31 | $14.52 Million | -12.82% |
| 2018-12-31 | $16.65 Million | +16.36% |
| 2017-12-31 | $14.31 Million | +47.87% |
| 2016-12-31 | $9.68 Million | +3.52% |
| 2015-12-31 | $9.35 Million | -8.30% |
| 2014-12-31 | $10.19 Million | +219.03% |
| 2013-12-31 | $3.20 Million | +90.21% |
| 2012-12-31 | $1.68 Million | -95.18% |
| 2000-12-31 | $34.88 Million | -- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more